Fragmento

1.- Dialyzer membrane permeabilityand survival in hemodialysis patients. 2.- Nonsteroidal anti-inflammatory drugs and risk of arf in the general population. 3.- HGM-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. 4.-Discordance of influence of hypertension on mortality and cardiovascular risk in hemodialysis patients 5.-Restless legs syndrome in patients after renal transplantation 6.- The efficacy of sidenafil for the treatment of erectile dysfunction in male peritoneal dialysis patients. 7.- A comparison of peritonitis rates from the United States renal data system database: CAPD versus continuous cycling peritoneal dialysis patients 8.- Usefulness of combination of high resolution ultrasonography and dual-phase dual-isotope iodine 123/technetium tc 99m Sestamibi Scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism 9.- Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients 10.- Hypertension in pediatric patients on long-term dialysis: a report of North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) 11.- Comparison of vascular access type in pediatric hemodialysis patients with respect of urea clearence, anemia management, and serum albumin concentration 12.- Proteinuria reduction and progression of renal failure in patients with type 2 diabetes mellitus and overt nephropathy PARA ESTA INFORMACIÓN, SUGERIMOS DESCARGAR FORMATO PDF.

Palabras clave:

2007-07-18   |   882 visitas   |   Evalua este artículo 0 valoraciones

Vol. 27 Núm.1. Enero-Marzo 2006 Pags. 27-32 Nefrol Mex 2006; 27(1)